Case report · 10 Aug 2026
Conference abstractPublished 14 May 2018
Protective effect of icariin on renal function in rats with type-2 diabetic nephropathy induced by HFD combined with low dose STZ via insulin signaling pathway
China Pharmaceutical University, China
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Objective: To investigate the ameliorative effect of icariin on renal function in rats with type-2 diabetic nephropathy and the potential mechanism of regulating the abnormality of insulin signal pathway in renal tissue. Method: Diabetes was induced in male SD rats by an intraperitoneal injection of STZ (40 mg/kg i.p.). Sustained blood glucose levels (>16.7 mmol/l) were considered as diabetic and for subsequent study. 100 rats were randomly divided into 5 groups: Control, diabetic, diabetic+icariin (60 mg/kg, i.g.), diabetic+icariin (120 mg/kg, i.g.), diabetic+metformin (200 mg/ kg, i.g.) administered 12 weeks from 9th to 21th week. Research was carried out at the beginning of 22th week. All rats were anaesthetized and then killed to remove kidneys. Blood glucose, Serum Creatinine (Cr), Serum Free Fatty Acid (FFAs), Total Cholesterol (TC), Serum Triglyceride (TG), Blood Urea Nitrogen (BUN), LDL-c and HDL-c in the kidney tissue were measured. Glomerular podocyte morphology was observed by light microscopy. Western blot was employed to determine the proteins levels of nephrin, desmin, PI3K-P85 and type-IV collagen. Result: The enhancement of blood glucose, Cr, FFAs, TC, TG, BUN and LDL-c was found in model group, which was significantly attenuated by icariin. The renal pathological changes in icariin treatment group were ameliorated, meanwhile decreased the expression of nephrin protein level as well as elevated desmin and collagen IV levels in renal tissue were significantly reversed by icariin. Furthermore, the icariin normalized insulin and PI3K-Akt signaling. Conclusion: Icariin can evidently relieve renal damage in rats with diabetic nephropathy, which might be related to modulating the lipid metabolism and insulin resistance.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical Trials.
Short communication · 31 Jul 2026
Understanding Bioavailability as a Key Element in Effective Therapeutic Delivery
Research article · 14 Jun 2026
Ensuring Rights and Dignity in Ethical Practices of Clinical Studies with Vulnerable Group and Safeguarding Vulnerable Group Act (2006)
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical Trials
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Qin Wang”
- BylineArticles whose byline prints “Xuan-Sheng Ding”
